FDA Drug Recalls

Recalls / Brands / Nexlizet

Nexlizet

2 FDA drug recalls involving brand “Nexlizet.

DateClassProductFirm
2024-03-27Class IIINEXLIZET (bempedoic acid and ezetimibe) tablets, 180 mg/10 mg, 30-count bottle, Rx only, Manufactured for: EspEsperion
2023-08-16Class IIINexlizet (bempedoic acid and ezetimibe), 180ng/18mg, 30 tablets, Rx only, Manufactured for: Esperion TherapeutEsperion